Immunohistochemical localization of cathepsin D in colorectal tumors

Diseases of the Colon and Rectum

Volumn 43, Issue 3, 2000, Pages 396-401

  Arao, Jun ^a   Fukui, Hirokazu ^b   Ono, Yuko ^a   Ueda, Yoshihiko ^a   Chiba, Tsutomu ^b   Fujimori, Takahiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cathepsin D; Colorectal carcinoma; Immunohistochemistry

Indexed keywords

CATHEPSIN D;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CATABOLISM; COLORECTAL TUMOR; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; PROTEIN EXPRESSION; SKIN FIBROBLAST; TUMOR LOCALIZATION;

EID: 0034116036     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02258308     Document Type: Article

References (19)

1. Tryggvason K, Höyhtyä M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217.
2. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 1988;48:3688-92.
3. Montcourrier P, Mangeat PH, Salazar G, Morisset M, Sahuquet A, Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large vesicles. Cancer Res 1990;50:6045-54.
4. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-8.
5. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 1980;20:353-62.
6. Thorpe SM, Rochefort H, Garcia M, et al. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 1989;49:6008-14.
7. Spyratos F, Maudelonde T, Brouillet JP, et al. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 1989;2:1115-8.
8. Kute TE, Shao ZM, Sugg NK, Long RT, Russell GB, Case LD. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassay and enzymatic assays. Cancer Res 1992;52: 5198-203.
9. Johnson MD, Torri JA, Lippman ME, Dickson RB. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 1993;53:873-7.
10. Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsin D, B and in human breast cancer. Hum Pathol 1994;25:857-62.
11. Sheahan K, Shuja S, Murnane MJ. Cystein protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989;49:3809-14.
12. Tumminello FM, Gebbia N, Pizzolanti G, Russo A, Bazan V, Leto G. Cathepsin D content in colorectal cancer. Oncology 1995;52:237-42.
13. Matsuo K, Kobayashi I, Tsukuba T, et al. Immunohistochemical localization of cathepsin D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells. Hum Pathol 1996;27:184-90.
14. Reig SH, Kim I, Janin A, et al. Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells. Int J Cancer 1996;68:479-84.
15. Gieselman V, Pohlmann R, Hasilik A, Von Figura K. Biosynthesis and transport of cathepsin D in cultured human fibroblast. J Cell Biol 1983;97:1-5.
16. Hasilik A, Von Figura K. Oligosaccharides in lysosomal enzymes: distribution of high-mannose and complex oligosaccharides in cathepsin D and β-hexosaminidase. Eur J Biochem 1981;121:125-9.
17. Rodriguez-Boulan E, Nelson WJ. Morphogenesis of the polarized epithelial cell phenotype. Science 1989;245: 718-24.
18. Valentini AM, Pirrelli M, Armentano R, Caruso ML. The immunohistochemical expression of cathepsin D in colorectal cancer. Anticancer Res 1996;16:77-80.
19. Mayer A, Fritz E, Fortelny R, Kofler K, Ludwig H. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer. Cancer Invest 1997;15:106-10.